Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by ilvmyt5son Feb 22, 2021 6:30pm
259 Views
Post# 32632776

Targeting a $200B+ Disruptive Global Opportunity

Targeting a $200B+ Disruptive Global OpportunitySponsored Post: Get in on the ground floor of North America's Largest Cannabis Company! The company operates through retail and wholesale channels in Canada and internationally. Join a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada!

Craft beer manufacturing and distribution infrastructurein the U.S. to build brand awareness ~40,000 on-premise and off-premisepoints of sale across 27 states. Opportunity to leverage platforms with new or existing brands forfurther U.S. expansion in CBD and other cannabinoids.  Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>